About this calculator

Demonstrates the different results obtained from various published creatinine clearance (CrCl) equations for a given set of patient data. This app is intended for teaching purposes only. For a detailed discussion see the Renally Excreted Drugs page.

Patient Parameters

Enter patient data below
years
mg/dl

Results — CrCl (ml/min)

Method CrCl
Cockcroft & Gault — Lean BW Eq 1
Cockcroft & Gault — Adjusted BW Eq 2
Cockcroft & Gault — Total BW Eq 3
Cockcroft & Gault — Normalized Eq 4
Jelliffe bedside method Eq 5
Jelliffe multi-step method Eq 6
Salazar & Corcoran Eq 7
CKD-EPI (2021) (calculates eGFR, not CrCl) Eq 8

Equations

  1. Cockcroft and Gault LBW
    CLCR Male = (Weight × [140 − Age]) / (SrCr × 72)
    CLCR Female = 85% of male value
    Weight = Lean Body Weight (LBW)
  2. Cockcroft and Gault Adjusted BW
    Same as above where Weight = Adjusted Body Weight (ABW):
    If TBW > LBW: ABW = LBW + (0.4 × [TBW − LBW])
  3. Cockcroft and Gault Total BW
    Same as above where Weight = Total Body Weight
  4. Cockcroft and Gault Normalized
    CLCR Male = (140 − Age) / SrCr
    CLCR Female = 85% of male value
  5. Jelliffe bedside method
    CLCR Male = (98 − [0.8 × (Age − 20)]) / SrCr
    CLCR Female = 90% of male value
  6. Jelliffe multi-step
    i. E (Male) = LBW × (29.305 − [0.203 × Age])
       E (Female) = LBW × (25.3 − [0.18 × Age])
    ii. CLCR/1.73 M2 = (E × 0.12) / (SrCr × BSA)
  7. Salazar and Corcoran
    CLCR Male = {(137 − Age) × [(0.285 × Wt) + (12.1 × Ht2)]} / (51 × SrCr)
    CLCR Female = {(146 − Age) × [(0.287 × Wt) + (9.74 × Ht2)]} / (60 × SrCr)
    Wt in kg, Ht in meters
  8. CKD-EPI (2021) Included for comparison only.
    eGFR should not be substituted for CrCl in pk modeling.
    eGFR = 142 × min(Scr/κ, 1)α × max(Scr/κ, 1)-1.200 × 0.9938Age [ × 1.012 if female ]
        κ (Kappa): 0.7 for females, 0.9 for males
        α (Alpha): -0.241 for females, -0.302 for males

References

  1. Lott RS, Hayton WL. Estimation of Creatinine Clearance from Serum Creatinine Concentration — a review. Drug Intell Clin Pharm 1978;12:140-150.
  2. Rhodes PJ, et al. Evaluation of Eight Methods for Estimating Creatinine Clearance in Men. Clin Pharm. 1987;6:399-406.
  3. Chow MS, Schweizer R. Estimation of Creatinine Clearance in Patients with Unstable Serum Creatinine Concentrations. Drug Intell Clin Pharm 1985;19:385-390.
  4. Jelliffe RW, Jelliffe SM. Estimation of creatinine clearance in patients with unstable renal function. Math Biosci. 14:17-24, 1972.
  5. Salazar DE, Corcoran GB. Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med. 1988;84(6):1053-60. [PubMed]
  6. Devine Ben. Gentamicin therapy. Drug Intell Clin Pharm 1974;8:650-6.
  7. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41. [PubMed]
  8. Winter MA, et al. Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation. Pharmacotherapy 2012;32(7):604-612.
  9. CKD-EPI Creatinine Equation (2021) National Kidney Foundation.